FirstRand Bank completes full capital reduction of FRC401 notes, cuts nominal amount to R 0
Bitget2026/10/08 14:55FirstRand Bank announced a full capital reduction of listed debt securities FRC401 (ISIN ZAG000185703), cutting the nominal amount to ZAR 0. Nominal amount reduced by ZAR 37,300,000 from ZAR 37,300,000, tied to a repurchase of the listed debt securities. Settlement amount set at ZAR 38,201,168, inclusive of accrued interest calculated under the pricing supplement. Accrued interest totals ZAR 901,168 on a 10.5% coupon, covering the 20 July 2026 to 12 October 2026 interest period. Record date is 9 October 2026. Pay/settlement date is 12 October 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FirstRand Bank Ltd. published the original content used to generate this news brief via SENS, the regulatory disclosure system operated by the Johannesburg Securities Exchange (JSE) (Ref. ID: S604653), on October 08, 2026, and is solely responsible for the information contained therein.
- FirstRand Bank announced a full capital reduction of listed debt securities FRC401 (ISIN ZAG000185703), cutting the nominal amount to ZAR 0.
- Nominal amount reduced by ZAR 37,300,000 from ZAR 37,300,000, tied to a repurchase of the listed debt securities.
- Settlement amount set at ZAR 38,201,168, inclusive of accrued interest calculated under the pricing supplement.
- Accrued interest totals ZAR 901,168 on a 10.5% coupon, covering the 20 July 2026 to 12 October 2026 interest period.
- Record date is 9 October 2026. Pay/settlement date is 12 October 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.
Dental treatment company vVardis has announced the terms for its $214 million US IPO.
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss
Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.
CoreWeave (CRWV.US) Faces Key Earnings Test: AI Cloud Debt Concerns Intensify as "Burning Cash for Growth" Model Faces Scrutiny
CoreWeave will release its third-quarter financial report. Whether it can demonstrate that its rapid revenue growth is sufficient to cover the rising financing costs and construction expenditures will directly determine the direction of market confidence.
Crypto prices
More
